PharmaCielo Ltd. (PCLO.V)
| Previous Close | 0.9500 |
| Open | 0.9400 |
| Bid | 0.9300 x 0 |
| Ask | 0.9500 x 0 |
| Day's Range | 0.8900 - 0.9200 |
| 52 Week Range | 0.8100 - 2.9400 |
| Volume | |
| Avg. Volume | 135,625 |
| Market Cap | 132.373M |
| Beta (5Y Monthly) | 3.28 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3020 |
| Earnings Date | Nov. 29, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.38 |
- Simply Wall St.
PharmaCielo (CVE:PCLO) investors are sitting on a loss of 49% if they invested a year ago
The simplest way to benefit from a rising market is to buy an index fund. When you buy individual stocks, you can make...
- CNW Group
PharmaCielo Completes Initial Tranche of Non-Brokered Private Placement of Debenture Units
PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), is pleased to announce that it has closed the first tranches of its previously announced non-brokered private placement (the "Offering"), consisting of an aggregate of 5,000 debenture units (each a "Unit"). The Units were issued at a price of $1,000 per Unit for agg
- CNW Group
PharmaCielo Announces $15.0 Million Non-Brokered Private Placement of Debenture Units
PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today announced that it has plans to issue up to 15,000 debenture units (each a "Unit") in a non-brokered private placement (the "Offering"). The Units will be issued at a price of $1,000 per Unit for aggregate gross proceeds of up to $15,000,000. Insiders, includin
